Abstract
IDF2022-0909 Sustainability of HbA1c control of tirzepatide vs insulin glargine in people with T2D and CV risk (SURPASS-4)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
